GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Retractable Technologies RVP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.56

-0.96%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Retractable Technologies

From its filings with the US Securities and Exchange Commission

SEC filings

Retractable Technologies is based in Little Elm, Texas and is incorporated in Texas. Its shares trade on NYSE under the ticker RVP. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $38.3m and a net loss of $12.6m. At that date it held total assets of $142.6m and shareholders' equity of $74.4m.

In its own words

Retractable Technologies, Inc. was incorporated in Texas in 1994. Our business is the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. We have manufacturing facilities in Little Elm, Texas and use manufacturers in China as well. Our syringes are well-suited for administering vaccinations.

On September 13, 2024, the Office of the U.S. Trade Representative (“USTR”) revealed final adjustments to increase tariffs on certain goods imported from China under Section 301 (“Section 301”) of the Trade Act of 1974 (“Trade Act”). Among those products included were syringes and needles, at a rate of 100%. Beginning in early 2025 and throughout much of the year, additional widespread tariffs were imposed on most products imported into the U.S. citing authority under the International Emergency Economic Powers Act (“IEEPA”). Those tariffs were in addition to the Section 301 tariffs which existed at the time. Throughout 2025, the prevailing tariff rates on various products and certain countries of origin, including many of our products, fluctuated greatly. These fluctuations negatively impacted our ability to predict the cost of importing certain goods or groups of goods and negatively impacted our business. In February 2026, the U.S. Supreme Court ruled that the President’s use of IEEPA to impose reciprocal tariffs exceeded his authority and that the IEEPA tariffs must be vacated. Looking forward after the Supreme Court’s ruling, the 2024 Section 301 tariff of 100% on syringes and needles from China remains unchanged.

Quoted from its 10-K, filed 27 Mar 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
4 May 2001
Employees
201
Head office
511 LOBO LANE, LITTLE ELM, TX, 75068-0009
Incorporated in
TX
Classification
Surgical & Medical Instruments & Apparatus
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. Thomas ShawChairman of the Board, President, Chief Executive Officer, Founder$1.2m
  • Mr. John FortChief Financial Officer, Vice President, Treasurer, Director, since 2019$309,000
  • Ms. Michele LariosVice President, General Counsel, Secretary$410,350
  • Mr. Walter BigbyIndependent Director$9,000
  • Mr. Darren FindleyIndependent Director$9,000
  • Mr. Marco LaterzaIndependent Director$10,000
  • Ms. Amy MackIndependent Director$8,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Retractable Technologies Inc (RTI) has several key strengths:

Weaknesses

  • Although RTI has various strengths, it also faces some weaknesses:

Opportunities

  • RTI can leverage the following opportunities to drive growth:

Threats

  • RTI should be cautious of the following potential threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.